Home
Clinical research done with precision, for sponsors and for our community.
A dedicated research site in Tampa with an on-site Phase I unit, fast start-up and a large local patient population across cardiometabolic, renal, respiratory, CNS and infectious disease studies.
A site built to activate quickly and enroll reliably.
Dedicated research facility in urban Tampa, minutes from Tampa International Airport (TPA), serving the Tampa–St. Petersburg–Clearwater metro area of more than 3.4 million people. Central IRB, parallel contracting and a coordinator team that knows the major EDC platforms.
Start-up & regulatory
- Central IRB: Advarra and WCG; submission packet ready 1 week before review
- Contract and budget negotiated in parallel with IRB submission
- Typical site selection to activation: about 8 weeks
- Start-up in under 3 days once the regulatory package is received
Phase I unit
- 6-bed unit for healthy-volunteer and patient-population studies
- In-patient admissions and overnight stays
- PK sampling up to 24 hours
- Infusion chairs and IV infusion capability; emergency crash cart
Equipment & IP
- 12-lead ECG on site
- Spirometry
- Ambient and refrigerated centrifuges; dry ice access
- 2–8 °C refrigerator, −20 °C and −80 °C freezers
- Locked, limited-access IP storage; retain-sample and archive storage
Imaging, lab & specialty access
- MRI, CT, X-ray, mammography and PET through local radiology partners
- Ophthalmology center access (e.g., fundus photography)
- Local CLIA-accredited laboratory partners in Tampa
Data & monitoring
- Experience with Medidata Rave, Oracle InForm and Veeva
- Read-only EMR access for monitors, limited to study participants
- Remote monitoring supported (secure source upload)
- Electronic regulatory and e-signature workflows
Visits & assessments
- Certified raters: MADRS, HAM-D, CDR, MMSE
- Weekend visits available
- Bilingual staff (English/Spanish)
- Clinic hours Monday–Friday, 9:00 AM–5:00 PM
- Adults 18–64 and older adults 65+
Research experience
Since 2018, our site has conducted industry-sponsored Phase II and Phase III studies in COVID-19 and respiratory infections, vaccines, COPD, hypertension, kidney disease, inflammatory bowel disease, eosinophilic GI disease and obesity.
Patient population
Our EMR gives us direct access to a large, diverse local population, including strong representation of Hispanic/Latino and Black or African American patients. Eligible patients are confirmed against each protocol’s criteria during feasibility.
Based on our EMR. Race and ethnicity are reported separately (Hispanic or Latino patients may be of any race). Condition-specific data is available on request during feasibility.
Therapeutic areas
Key indications
Experienced investigators, hands-on coordination.
Help shape the treatments of tomorrow.
Clinical studies test new medicines and vaccines before they reach the public. Volunteers who take part receive close medical attention from our team, and every study is reviewed by an independent ethics board (IRB).
Contact us
Sign up online, call or email us. We’ll ask a few general questions to see which studies may fit.
Learn about the study
Our staff explains the study, its visits, possible risks and benefits. You review the consent form and ask any questions.
Decide — it’s your choice
Participation is always voluntary. You can stop at any time without affecting your regular medical care.
What participants can expect
- Study-related visits, tests and study medicine at no cost
- Compensation for time and travel may be available, depending on the study
- Regular check-ups and lab work with our medical team
- Weekend visits available for some studies
Conditions we study
Type 2 diabetes · Weight management · High blood pressure · Kidney disease · COPD and asthma · Depression and anxiety · Memory and Alzheimer’s · COVID-19, RSV and flu · Healthy volunteers
¿Quiere participar en un estudio?
Llámenos al (813) 513-2365 o escríbanos. Le explicaremos los estudios disponibles y si podría calificar. La participación es voluntaria.
Join our volunteer list
Sign up online in about 2 minutes and we will call you when a study opens that may fit you. You can also call us.
Sign up online — Regístrese aquí Call (813) 513-2365 Email us — EscríbanosQuestions about participating
What is a clinical trial?
A clinical trial is a research study that tests whether an investigational medicine, vaccine or treatment is safe and works. Every new medicine available today was first tested in clinical trials with volunteers.
Who can participate?
Each study has its own requirements, such as age, diagnosis and current medications. Our team asks a few general questions by phone and, if a study may fit, invites you to a screening visit to confirm eligibility.
Do I need health insurance?
No. You do not need health insurance to take part. Study-related visits, tests and study medicine are provided at no cost to you.
Will I be paid for my time?
Many studies offer compensation for time and travel. The amount depends on the study and is explained before you decide to participate.
Is it safe?
Every study is reviewed and approved by an independent ethics board (IRB) before it starts. Our medical team monitors your health at each visit, and all known risks are explained to you in the consent form before you agree to participate.
Could I receive a placebo?
Some studies compare the investigational treatment with a placebo (an inactive substance) or with a standard treatment. The consent form tells you whether the study uses a placebo and what your chances are of receiving it.
Can I stop participating?
Yes. Participation is always voluntary, and you can leave a study at any time, for any reason, without affecting your regular medical care.
Will my information be kept private?
Yes. Your personal and health information is protected under HIPAA and is shared only as described in the consent form. Study data is identified by a code, not by your name.
Can I keep seeing my regular doctor?
Yes. You keep your regular doctor. Some studies may require changes to certain medications; our team will review your medications with you before you start.
Let’s work together.
Sponsors and CROs: send us your CDA and feasibility questionnaire and we’ll respond promptly. Once the CDA is executed, we review the protocol and confirm patient numbers.